Brugada-like cardiac disease in myotonic dystrophy type 2: Report of two unrelated patients

European Journal of Neurology

Volumn 18, Issue 1, 2011, Pages 191-194

  Rudnik Schoneborn S ^a   Schaupp, M ^b   Lindner, A ^b   Kress, W ^c   Schulze Bahr, E ^d   Zumhagen, S ^d   Elbracht, M ^a   Zerres, K ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b MARIENHOSPITAL STUTTGART   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Brugada syndrome; Cardiac arrhythmias; Myotonic dystrophy type 2; Proximal myotonic myopathy

Indexed keywords

ALANINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CHOLESTEROL; CYSTEINE; LIVER ENZYME; SODIUM CHANNEL NAV1.5; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRUGADA SYNDROME; CASE REPORT; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; FAMILY HISTORY; FATIGUE; GENE SEQUENCE; GENETIC VARIABILITY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MISSENSE MUTATION; MUSCLE STIFFNESS; MYOTONIA; MYOTONIC DYSTROPHY; MYOTONIC DYSTROPHY TYPE 2; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; ST SEGMENT ELEVATION; SYNCOPE; TRIACYLGLYCEROL BLOOD LEVEL; COMPLICATION; GENETICS; MIDDLE AGED;

ADULT; BRUGADA SYNDROME; HUMANS; MALE; MIDDLE AGED; MYOTONIC DYSTROPHY;

EID: 78650096150     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03077.x     Document Type: Article

References (9)

1. Liquori C, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001; 293: 864-867.
2. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Eng J Med 2008; 358: 2688-2697.
3. Day JW, Ricker K, Jacobsen BS, et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003; 60: 657-664.
4. Wahbi K, Meune C, Bécane HM, et al. Left ventricular dysfunction and cardiac arrhythmias are frequent in type 2 myotonic dystrophy: a case control study. Neuromuscul Disord 2009; 19: 468-472.
5. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference. Circulation 2005; 111: 659-670.
6. Hedley PL, Jorgensen P, Schlamovitz S, et al. The genetic basis of Brugada syndrome. A mutation update. Hum Mutat 2009; 30: 1256-1266.
7. Schoser BG, Kress W, Walter MC, Halliger-Keller B, Lochmüller H, Ricker K. Homozygosity for CCTG mutation in myotonic dystrophy type 2. Brain 2004; 127: 1868-1877.
8. Ranum LPW, Cooper TA. RNA-mediated neuromuscular disorders. Ann Rev Neurosci 2006; 29: 259-277.
9. Wahbi K, Fressart V, Bécane HM, et al. High prevalence of Brugada syndrome in patients with Steinert's disease. Medgen 2009; 21: 423. (abstr S9-04).